93 completed, 49 unknown, 14 terminated, 12 withdrawn. 35 Not applicable, 31 Phase 2, 24 Phase 3, 9 Phase 1, 5 Phase 4.
Follow SARS-CoV Infection: new trials by email Literature Review of SARS-CoV Infection trials Research Report on SARS-CoV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome Instilled T3, Placebo Therapy - Covid19, SARS-CoV Infection | Phase 2 | Withdrawn | University of Minnesota | 2026-01-15 | 2026-02-10 | |
| Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 Mitoquinone/mitoquinol mesylate, Placebo - SARS-CoV Infection, COVID-19 | Phase 2 | Completed | University of Texas Southwestern Medical Center | 122 | 2024-03-01 | 2026-09-21 |
| Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing? An Oropharyngeal swab - SARS-CoV Infection, Coronavirus | Not applicable | Unknown | Copenhagen University Hospital, Rigshospitalet | 1000 | 2022-11-10 | 2023-01-11 |
| COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes Fisetin, Placebo - Covid19, SARS-CoV Infection | Phase 2 | Terminated | Mayo Clinic | 20 | 2022-04-29 | 2025-08-26 |
| '4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission Coaching, Cleaning, Communication, Collaboration - SARS-CoV Infection, Covid19 | Not applicable | Withdrawn | University of Michigan | 2021-12-04 | 2021-11-19 | |
| SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial Shampoo and saline, Saline and Listerine, Shampoo and Listerine - Covid19, SARS-CoV Infection | Phase 2 / Phase 3 | Terminated | Milton S. Hershey Medical Center | 171 | 2021-10-01 | 2026-09-14 |
| Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort. biobank - SARS-CoV Infection, Covid19 | Completed | ANRS, Emerging Infectious Diseases | 756 | 2021-09-21 | 2025-05-28 | |
| Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine ICC Vaccine, qNIV Nanoparticle Vaccine2 in-clinic mixed with Matrix-M1 Adjuvant, SARS-CoV-2 rS Nanoparticle Vaccine in-clinic mixed with Matrix-M1 Adjuvant - SARS-CoV Infection, Covid19 | Phase 1 / Phase 2 | Completed | Novavax | 637 | 2021-09-08 | 2025-04-10 |
| Baromètre Santé Adulte 2021-2022 Blood sample - Diabetes, Hypercholesterolemia | Not applicable | Suspended | Agence Sanitaire et Sociale de Nouvelle Calédonie | 5471 | 2021-07-26 | 2022-02-01 |
| Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept COVID-19 RT-PCR, Biosensor - SARS-CoV Infection, Covid19 | Completed | University Hospital, Lille | 200 | 2021-07-07 | 2024-12-13 | |
| Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients Ozonized oil (HOO - SARS-CoV Infection | Not applicable | Withdrawn | Neuromed IRCCS | 2021-07-01 | 2022-01-26 | |
| Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP) Clinical follow-up for 24 months - Covid19, SARS-CoV Infection | Unknown | Universidad de la Sabana | 50 | 2021-07-01 | 2021-06-30 | |
| Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine QazCoVac-P -COVID-19 Subunit Vaccine, Placebo - Covid19, SARS-CoV Infection | Phase 1 / Phase 2 | Completed | Research Institute for Biological Safety Problems | 244 | 2021-06-15 | 2023-12-07 |
| The DAWN Antivirals Trial for Ambulatory COVID-19 Patients Camostat, Placebo, Molnupiravir - Covid19, SARS-CoV Infection | Phase 3 | Terminated | KU Leuven | 44 | 2021-06-15 | 2022-10-03 |
| Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19 Placebo administration, Confirm SARS-CoV-2 infection, Physical Examination - Corona Virus Infection, Covid19 | Phase 3 | Unknown | MGC Pharmaceuticals d.o.o | 252 | 2021-06-11 | 2022-08-24 |
| VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study VERU-111 - SARS-CoV Infection | Phase 3 | Completed | Veru Inc. | 204 | 2021-05-18 | 2026-09-10 |
| GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) GLS-1027, Placebo - Pneumonitis, SARS-CoV Infection | Phase 2 | Completed | GeneOne Life Science, Inc. | 132 | 2021-05-07 | 2025-04-11 |
| Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19) Essence oils - Covid19, SARS-CoV Infection | Not applicable | Unknown | Universidade do Estado do Pará | 350 | 2021-05-01 | 2021-02-21 |
| Policy Responses Against the COVID-19 Pandemic in Latin America Social and public health measures against COVID-19, Control - Covid19, Infectious Disease | Unknown | University of Chile | 10000 | 2021-04-28 | 2021-04-28 | |
| Sargramostim Use in COVID-19 to Recover Patient Health Sargramostim, Placebo - Covid19, SARS-CoV Infection | Phase 2 | Completed | Partner Therapeutics, Inc. | 600 | 2021-04-27 | 2023-02-06 |
Showing 20 of 174. Sign in to see all of them.
Severe Acute Respiratory Syndrome (174) · COVID-19 (141) · Coronavirus Infections (39) · Respiratory Distress Syndrome (9) · Communicable Diseases (6) · Pneumonia, Viral (5) · Critical Illness (4) · Pneumonia (4) · Anosmia (3) · Anxiety Disorders (3) · Disease (3) · Virus Diseases (3) · Acute Kidney Injury (2) · Arthritis, Rheumatoid (2) · Chikungunya Fever (2)
Coronaviridae Infections (174) · Nidovirales Infections (174) · RNA Virus Infections (174) · Respiratory Tract Diseases (174) · Respiratory Tract Infections (173) · Infections (172) · Virus Diseases (171) · Lung Diseases (143) · Pneumonia (137) · Pneumonia, Viral (136) · Coronavirus Infections (135) · Pathological Conditions, Signs and Symptoms (28) · Pathologic Processes (23) · Disease Attributes (15) · Respiration Disorders (10)
Hydroxychloroquine (7) · Blood Specimen Collection (4) · Cholecalciferol (4) · Losartan (4) · COVID-19 Vaccines (3) · Ivermectin (3) · Sodium Chloride (3) · Standard of Care (3) · Vitamin D (3) · remdesivir (3) · Ascorbic Acid (2) · BBV152 COVID-19 vaccine (2) · COVID-19 Serological Testing (2) · Chloroquine (2) · Hematologic Tests (2)
Direction Centrale du Service de Santé des Armées (6) · University of Minnesota (6) · Lahore General Hospital (5) · University Hospital, Montpellier (5) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (3) · Research Institute for Biological Safety Problems (3) · Assistance Publique - Hôpitaux de Paris (2) · Bharat Biotech International Limited (2) · Chelsea and Westminster NHS Foundation Trust (2) · Children's Hospital Medical Center, Cincinnati (2) · Copenhagen University Hospital, Rigshospitalet (2) · Fayoum University (2) · Hospital Sultanah Bahiyah (2) · Insel Gruppe AG, University Hospital Bern (2) · Institut Pasteur (2)
United States (44) · France (25) · Brazil (13) · United Kingdom (9) · Belgium (8) · Italy (7) · Pakistan (6) · Canada (5) · Egypt (4) · Mexico (4) · Switzerland (4) · Argentina (3) · Denmark (3) · Kazakhstan (3) · Netherlands (3)
Vincent Foulongne, PhD (3) · Berik Khairullin, PhD (2) · Christopher Tignanelli, MD (2) · Claude Flamand, PhD (2) · Kunsulu Zakarya, PhD (2) · Michael Puskarich, MD, MS (2) · Muhammad Irfan Malik, FCPS (2) · Paramjeet Deol, MBChB FRCEM (2) · Sardar Al-Fareed Zafar (2) · Simiso Sokhela (2) · Siti Sabzah Mohd Hashim, MD MS (2) · Alessandra Familiari (1) · Alexander Supady, Dr., MPH (1) · Amin Roshdy, PHD (1)
PMID 32492293, PMID 32658300, PMID 32673060, PMID 21672157, PMID 25072119, PMID 30876620, PMID 31024571, PMID 31464823, PMID 31477039, PMID 31986264, PMID 32073213, PMID 32243281, PMID 32302438, PMID 32302448, PMID 32304646, PMID 32325026, PMID 32330083, PMID 32330277, PMID 32492354, PMID 32595361, PMID 32607303, PMID 32640463, PMID 32645713, PMID 32650305, PMID 32670091, PMID 32728349, PMID 32733907, PMID 32780788, PMID 32785669, PMID 32785710, PMID 32787470, PMID 32848205, PMID 32868447, PMID 32944767, PMID 33125914, PMID 33146320, PMID 33151337, PMID 33165621, PMID 33168562, PMID 33190397, PMID 33204764, PMID 33226117, PMID 33274360, PMID 33301246, PMID 33310111, PMID 33326716, PMID 33340043, PMID 33521007, PMID 33570583, PMID 33579579
P30AG024824 (1), R01AG072301 (1)